Skip to main content
  • Tweet
  • Share on Facebook
  • Share on Google +1
  • Share via Email
  • Contact
  • Glossary
  • Jobs
  • Subscribe
  • Search

Malaria Vaccine Initiative

Accelerating Malaria Vaccine Development

  • About us
    • Mission and vision
    • Our team
    • Governance
      • Technical Advisory Groups
      • Vaccine Science Portfolio Advisory Council
    • Our role in the malaria vaccine community
    • Our partners
    • Donors
    • Donate
    • Jobs
    • Contact us
  • Malaria and vaccines
    • Need for a vaccine
    • Malaria vaccine roadmap
    • First-generation vaccine
      • RTS,S
    • Next-generation vaccines
      • Preventing transmission
      • Preventing infection
    • Vaccine development
      • Our research and development strategy
      • Life cycle of the malaria parasite
      • Preferred product characteristics
    • Evaluation technologies
    • Access
      • Data for decision-making
        • Decision-making framework
          • Economic analysis
          • Public health impact analysis
          • Sociocultural research
      • Policy and regulatory pathways
        • Regulatory decisions and prequalifications
        • Policy
      • Financing
        • Gavi, the Vaccine Alliance
        • Other fincancing mechanisms
  • Projects
    • Search vaccine projects
    • Evaluation technology projects
    • MVI Portfolio
    • Past projects
  • Resources
    • Search all resources
    • Fact sheets
    • Journal articles
    • Presentations
    • Videos
    • Reports
    • PATH Vaccine Resource Library
  • News and events
    • Press releases
    • Inside MVI
    • From the field
    • Malaria vaccine news
    • Events
      • Find us here
      • Past events
  • Work with us
    • RFPs
    • Advocacy
      • Malaria Vaccine Advocacy Fellowship
      • Past advocacy fellows
      • Tools for advocates
    • Propose a project
  • About us
    • Mission and vision
    • Our team
    • Governance
      • Technical Advisory Groups
      • Vaccine Science Portfolio Advisory Council
    • Our role in the malaria vaccine community
    • Our partners
    • Donors
    • Donate
    • Jobs
    • Contact us
  • Malaria and vaccines
    • Need for a vaccine
    • Malaria vaccine roadmap
    • First-generation vaccine
      • RTS,S
    • Next-generation vaccines
      • Preventing transmission
      • Preventing infection
    • Vaccine development
      • Our research and development strategy
      • Life cycle of the malaria parasite
      • Preferred product characteristics
    • Evaluation technologies
    • Access
      • Data for decision-making
      • Policy and regulatory pathways
      • Financing
  • Projects
    • Search vaccine projects
    • Evaluation technology projects
    • MVI Portfolio
    • Past projects
  • Resources
    • Search all resources
    • Fact sheets
    • Journal articles
    • Presentations
    • Videos
    • Reports
    • PATH Vaccine Resource Library
  • News and events
    • Press releases
    • Inside MVI
    • From the field
    • Malaria vaccine news
    • Events
      • Find us here
      • Past events
  • Work with us
    • RFPs
    • Advocacy
      • Malaria Vaccine Advocacy Fellowship
      • Past advocacy fellows
      • Tools for advocates
    • Propose a project
  • Home
  • Home

Research for implementation: Challenges of tracking funding flows highlighted in new report

Pilot survey of funders reveals challenges of tracking money; case studies show potential impact of this research on uptake and usability of drugs, diagnostics, vector control products, and vaccines. Read more...

PATH to attend 7th Multilateral Initiative on Malaria (MIM) Pan African Malaria Conference

PATH researchers will share new research in malaria diagnostics, drugs, and vaccines, and share insights on how to accelerate the fight against malaria globally and within sub-Saharan Africa.  Read more...

PATH/Doune Porter

Test your knowledge to help end malaria

We’re asking you to put your knowledge to the test with a three-question quiz. Ready to begin?

Home

  • MVI Portfolio

    We strategically use our resources to support and advance a range of vaccine approaches that target both humoral and cellular immunity. 
    Explore
  • Evaluation technology projects

    We partner to develop and optimize new assays and challenge models and support reference and service laboratories.
    Explore
  • RTS,S

    Ghana, Kenya, and Malawi to take part in WHO malaria vaccine pilot programme
    Explore

Latest

RTS,S Frequently Asked Questions (FAQs)
Fact sheet
18 Apr 2018
Investigating a second valley of death in malaria R&D
Report
16 Apr 2018
The RTS,S malaria vaccine
Fact sheet
16 Apr 2018
ASTMH 67th Annual Meeting
Event
31 Oct 2018
7th Multilateral Initiative on Malaria (MIM) Pan African Conference
Event
15 Apr 2018
PATH's Malaria Vaccine Initiative
Fact sheet
13 Apr 2018
Keystone Symposia: Emerging Technologies in Vaccine Discovery and Development
Event
28 Jan 2018
G-Finder 2017 Report
Report
13 Dec 2017
malERA–An updated research agenda for malaria elimination and eradication
Report
30 Nov 2017
World Malaria Report 2017
Report
28 Nov 2017
Regaining progress against malaria requires new tools
From the field
28 Nov 2017
Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25
Journal article
16 Nov 2017
  • Need for a vaccine

    A vaccine could help to close the gap left by other malaria control interventions.
  • Malaria vaccine roadmap

    The roadmap outlines a path for accelerating the development of malaria vaccines.
  • First-generation vaccine

    A first malaria vaccine would be used in addition to existing malaria control tools.
  • Next-generation vaccine

    The next generation of malaria vaccines would aim to reduce transmission of the parasite.

Work with us

We work with partners in private industry, government, and academia to develop safe and effective vaccines. Explore

Twitter @MalariaVaccine

RT @TR_Foundation: #Malaria in #conflict zones threatens global progress against the disease: https://t.co/ymLcToKIqR | @nelliepeyton… https://t.co/WVDIlFQA1p
21 Apr 2018
RT @PATHtweets: At #CHOGM2018, 53 #Commonwealth nations commit to halve #malaria cases by 2023. We’re proud to support this effort… https://t.co/ZcQbRHwR3g
20 Apr 2018
RT @malariamustdie: We’ve done it! 53 Commonwealth nations have heard our call and taken the action we’ve been fighting for: a commitme… https://t.co/qYI7WcY5KK
20 Apr 2018
Dr. Ashley Birkett, @MalariaVaccine: We now have solid proof of concept data in field trials for #malaria transmiss… https://t.co/DZUE7a08Ra
20 Apr 2018
Dr. Issaka Sagara, MRTC discusses #malaria transmission blocking vaccine field trials that have been conducted in M… https://t.co/dWRvG8uMib
20 Apr 2018
Dr. Ashley Birkett, @MalariaVaccine: We need new tools with longer durability. A #vaccine with high efficacy and lo… https://t.co/gjXsL85BCV
20 Apr 2018
Join us in the CICAD press conference room for symposium, Progress in #Malaria Transmission Blocking Vaccine Develo… https://t.co/k4Z5XOigbv
20 Apr 2018
Dr. Scott Gordon, @PATHtweets discusses the qualitative component of the RTS,S Malaria Vaccine Implementation Progr… https://t.co/N2Tu8ytyWo
19 Apr 2018
Great presentation by Dr. Rose Jalang'o, @MOH_Kenya: The RTS,S #malaria #vaccine will be introduced through the nat… https://t.co/znXWpcDmID
19 Apr 2018
Happening now at #MIM2018: Introduction to the RTS,S #Malaria Vaccine Implementation Programme symposium. Join us i… https://t.co/2R7MEzQlHK
19 Apr 2018
Dr. Adrian Hill, @JennerInstitute: There is minimal funding of preclinical research in Africa. This needs to change. #MIM2018
19 Apr 2018
Dr. Birkett: There is real promise in combination #vaccines. However, also have to think about cost. The more compo… https://t.co/4jOH7gOkQs
19 Apr 2018

PATH Malaria Vaccine Initiative

455 Massachusetts Avenue NW, Suite 1000

Washington, DC 20001 | USA 

Tel: 202.822.0033

Fax: 202.457.1466

Email: mvi_info [at] path.org

PATH Headquarters

2201 Westlake Avenue, Suite 200

Seattle, WA 98121 | USA 

Tel: 206.285.3500

Fax: 206.285.6619

Email: info [at] path.org

Website: www.path.org

Follow us

Mail
Twitter
  • Privacy policy
  • Copyright policy
  • Terms of use
© 2018 Malaria Vaccine Initiative
Website by Manta Ray Media